GHDX
Genomic Health, Inc.
GHDX
GHDX
Delisted
GHDX was delisted on the 7th of November, 2019.
107 hedge funds and large institutions have $847M invested in Genomic Health, Inc. in 2014 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 31 increasing their positions, 43 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
33% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 12
37% less call options, than puts
Call options by funds: $1.79M | Put options by funds: $2.84M
Holders
107
Holding in Top 10
2
Calls
$1.79M
Puts
$2.84M
Top Buyers
| 1 | +$34M | |
| 2 | +$13.3M | |
| 3 | +$8.25M | |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$7.79M |
| 5 |
Millennium Management
New York
|
+$2.85M |
Top Sellers
| 1 | -$15.1M | |
| 2 | -$8.75M | |
| 3 | -$5.71M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$4.33M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$1.63M |